| Dr Brian James Miller, MD, MBA, MPH | |
|
600 N Wolfe St., Meyer 8-134-h, Baltimore, MD 21287 | |
| (410) 955-9434 | |
| Not Available |
| Full Name | Dr Brian James Miller |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 13 Years |
| Location | 600 N Wolfe St., Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407294705 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johns Hopkins Hospital, The | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 4981745098 | 571 |
News Archive
Transave Inc., today reported additional positive clinical trial results on its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation), an antibiotic that aims to treat chronic lung infections.
Gilead Sciences, Inc. announced today its results of operations for the quarter ended June 30, 2010. Total revenues for the second quarter of 2010 were $1.93 billion, up 17 percent compared to total revenues of $1.65 billion for the second quarter of 2009. Net income for the second quarter of 2010 was $712.1 million, or $0.79 per diluted share, compared to net income for the second quarter of 2009 of $571.4 million, or $0.61 per diluted share.
By analyzing complex interactions of the immune system in an animal study, pediatric researchers have found potential tools for controlling a life-threatening condition called a cytokine storm that may strike children who have juvenile arthritis and other autoimmune diseases.
The National Viral Hepatitis Roundtable (NVHR) is hosting a briefing, "The Experts' Perspective: Gaps and Strategies in the Hepatitis Crisis." "Leading hepatitis physicians, one of whom is a Congressman, will be on the hill today to educate Congress on the importance of developing a strategy to reduce the significant morbidity and mortality from end-stage liver disease and liver cancer caused by chronic hepatitis B and chronic hepatitis C in the United States," said Martha Saly, Director of NVHR.
› Verified 2 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1902332133 PECOS PAC ID: 4981745098 Enrollment ID: O20170818000085 |
News Archive
Transave Inc., today reported additional positive clinical trial results on its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation), an antibiotic that aims to treat chronic lung infections.
Gilead Sciences, Inc. announced today its results of operations for the quarter ended June 30, 2010. Total revenues for the second quarter of 2010 were $1.93 billion, up 17 percent compared to total revenues of $1.65 billion for the second quarter of 2009. Net income for the second quarter of 2010 was $712.1 million, or $0.79 per diluted share, compared to net income for the second quarter of 2009 of $571.4 million, or $0.61 per diluted share.
By analyzing complex interactions of the immune system in an animal study, pediatric researchers have found potential tools for controlling a life-threatening condition called a cytokine storm that may strike children who have juvenile arthritis and other autoimmune diseases.
The National Viral Hepatitis Roundtable (NVHR) is hosting a briefing, "The Experts' Perspective: Gaps and Strategies in the Hepatitis Crisis." "Leading hepatitis physicians, one of whom is a Congressman, will be on the hill today to educate Congress on the importance of developing a strategy to reduce the significant morbidity and mortality from end-stage liver disease and liver cancer caused by chronic hepatitis B and chronic hepatitis C in the United States," said Martha Saly, Director of NVHR.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian James Miller, MD, MBA, MPH 600 N Wolfe St, Baltimore, MD 21287-0005 Ph: (410) 614-4474 | Dr Brian James Miller, MD, MBA, MPH 600 N Wolfe St., Meyer 8-134-h, Baltimore, MD 21287 Ph: (410) 955-9434 |
News Archive
Transave Inc., today reported additional positive clinical trial results on its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation), an antibiotic that aims to treat chronic lung infections.
Gilead Sciences, Inc. announced today its results of operations for the quarter ended June 30, 2010. Total revenues for the second quarter of 2010 were $1.93 billion, up 17 percent compared to total revenues of $1.65 billion for the second quarter of 2009. Net income for the second quarter of 2010 was $712.1 million, or $0.79 per diluted share, compared to net income for the second quarter of 2009 of $571.4 million, or $0.61 per diluted share.
By analyzing complex interactions of the immune system in an animal study, pediatric researchers have found potential tools for controlling a life-threatening condition called a cytokine storm that may strike children who have juvenile arthritis and other autoimmune diseases.
The National Viral Hepatitis Roundtable (NVHR) is hosting a briefing, "The Experts' Perspective: Gaps and Strategies in the Hepatitis Crisis." "Leading hepatitis physicians, one of whom is a Congressman, will be on the hill today to educate Congress on the importance of developing a strategy to reduce the significant morbidity and mortality from end-stage liver disease and liver cancer caused by chronic hepatitis B and chronic hepatitis C in the United States," said Martha Saly, Director of NVHR.
› Verified 2 days ago
Dr. Ken Lin Tai, M.D., M.P.H. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 201 W Preston St, Room 304b, Baltimore, MD 21201 Phone: 410-767-2036 | |
James D Levy, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 323 N Calvert St, Baltimore, MD 21202 Phone: 410-332-9240 Fax: 410-962-8398 | |
Dr. Eileen Karen Steinberger, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 660 W Redwood St, Sutie 100d, Baltimore, MD 21201 Phone: 410-767-0789 Fax: 410-333-5210 | |
Dr. Jorge Ernesto Calderon, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 4000 Annapolis Rd, Suite 201, Baltimore, MD 21227 Phone: 410-636-2222 Fax: 410-789-4688 | |
Dr. Taiwo Olubanke Lawoyin, MD, MPH, CPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 Armory Pl, Suite 3m, Baltimore, MD 21201 Phone: 410-225-8615 | |
Dr. Paul B Spiegel, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 615 N Wolfe St, Baltimore, MD 21205 Phone: 443-326-8050 | |
Shelly Seungah Choo, M.D., M.P.H Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1001 E Fayette St, Baltimore, MD 21202 Phone: 410-396-1834 |